|
|
Blood, 15 September 2004, Vol. 104, No. 6, pp. 1760-1768.
Prepublished online as a Blood First Edition Paper on June 8, 2004; DOI 10.1182/blood-2003-12-4244.
Previous Article | Next Article 
Submitted December 15, 2003
Accepted May 17, 2004
Notch4-induced inhibition of endothelial sprouting requires the ankyrin repeats and involves signaling through RBP-J
Farrell MacKenzie, Patrick Duriez, Bruno Larrivee, Linda Chang, Ingrid Pollet, Fred Wong, Calvin Yip, and Aly Karsan*
Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada; Medical Biophysics, British Columbia Cancer Agency, Vancouver, BC, Canada
Experimental Medicine, University of British Columbia, Vancouver, BC, Canada; Medical Biophysics, British Columbia Cancer Agency, Vancouver, BC, Canada
Medical Biophysics, British Columbia Cancer Agency, Vancouver, BC, Canada
Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada; Experimental Medicine, University of British Columbia, Vancouver, BC, Canada; Pathology and Laboratory Medicine, British Columbia Cancer Agency, Vancouver, BC, Canada
* Corresponding author; email: akarsan{at}bccrc.ca.
Notch proteins comprise a family of transmembrane receptors. Ligand activation of Notch releases the intracellular domain of the receptor that translocates to the nucleus and regulates transcription through the DNA-binding protein RBP-J . Previously, it has been shown that the Notch4 intracellular region (N4IC) can inhibit endothelial sprouting and angiogenesis. Here, N4IC deletion mutants were assessed for their ability to inhibit human microvascular endothelial cell (HMEC) sprouting using a quantitative endothelial sprouting assay. Deletion of the ankyrin repeats, but not the RAM domain or C-terminal region (CT), abrogated the inhibition of FGF-2- and VEGF-induced sprouting by Notch4, while the ankyrin repeats alone partially blocked sprouting. The ankyrin repeats were also the only domain required for upregulation of RBP-J -dependent gene expression. Interestingly, enforced expression of the ankyrin domain alone was sufficient to upregulate some, but not all, RBP-J -dependent genes. Although N4IC reduced VEGF receptor-2 (VEGFR-2) and VE-cadherin expression, neither of these events is necessary and sufficient to explain N4IC-mediated inhibition of sprouting. A constitutively-active RBP-J mutant significantly inhibited HMEC sprouting, but not as strongly as N4IC. Thus, Notch4-induced inhibition of sprouting requires the ankyrin repeats and appears to involve RBP-J -dependent and -independent signaling.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Roca and R. H. Adams
Regulation of vascular morphogenesis by Notch signaling
Genes & Dev.,
October 15, 2007;
21(20):
2511 - 2524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wu and E. H. Bresnick
Glucocorticoid and Growth Factor Synergism Requirement for Notch4 Chromatin Domain Activation
Mol. Cell. Biol.,
March 15, 2007;
27(6):
2411 - 2422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Suchting, C. Freitas, F. le Noble, R. Benedito, C. Breant, A. Duarte, and A. Eichmann
The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching
PNAS,
February 27, 2007;
104(9):
3225 - 3230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Murphy, B. Larrivee, I. Pollet, K. S. Craig, D. E. Williams, X.-H. Huang, M. Abbott, F. Wong, C. Curtis, T. P. Conrads, et al.
Identification of Sokotrasterol Sulfate As a Novel Proangiogenic Steroid
Circ. Res.,
August 4, 2006;
99(3):
257 - 265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Leong and A. Karsan
Recent insights into the role of Notch signaling in tumorigenesis
Blood,
March 15, 2006;
107(6):
2223 - 2233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hu, A. Dievart, M. Lupien, E. Calvo, G. Tremblay, and P. Jolicoeur
Overexpression of Activated Murine Notch1 and Notch3 in Transgenic Mice Blocks Mammary Gland Development and Induces Mammary Tumors
Am. J. Pathol.,
March 1, 2006;
168(3):
973 - 990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Patel, J.-L. Li, D. Generali, R. Poulsom, D. W. Cranston, and A. L. Harris
Up-regulation of Delta-like 4 Ligand in Human Tumor Vasculature and the Role of Basal Expression in Endothelial Cell Function
Cancer Res.,
October 1, 2005;
65(19):
8690 - 8697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wu, F. Iwata, J. A. Grass, C. S. Osborne, L. Elnitski, P. Fraser, O. Ohneda, M. Yamamoto, and E. H. Bresnick
Molecular Determinants of NOTCH4 Transcription in Vascular Endothelium
Mol. Cell. Biol.,
February 15, 2005;
25(4):
1458 - 1474.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|